The North America hereditary testing market accounted for USD 5.98 billion in 2025. The market growth is being driven by advancements in precision medicine, expansion of the rare disease diagnosis ecosystem, significant prevalence of hereditary and rare diseases, and expansion of relevant infrastructure. These trends were evaluated by our Senior Research Analyst, Deepa Pandey, to curate this well-researched report. Her analysis benefits pharmaceutical producers, distributors, medical professionals, and stakeholders in performing competitive analysis and informed decision-making.